Breast cancer is the most common cancer in the UK, with around 55,200 people diagnosed each year. It starts in the breast tissue, most commonly in cells lining the milk ducts. Breast cancer predominantly affects women, but men can get it too.
Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.
We’ve helped Google Health with AI research which has the potential to improve breast cancer screening and save the NHS time and money.
The Personalised Breast Cancer Programme in Cambridge is pioneering ways to tackle hard-to-treat breast cancer.
Rachel, from East Sussex, shares how her sister Thekla’s breast cancer diagnosis has affected the family so far.
New computer simulation study suggests only screening women deemed at a ‘high risk’ of breast cancer could help to reduce unnecessary diagnoses.
In the immediate aftermath, estimating the numbers affected by a breast screening error might do more harm than good.
With new cancer detection technology on the horizon, ranging from blood tests to wristbands, understanding overdiagnosis is a huge challenge.
Our researchers have discovered a way to halt breast cancer spread in mice, by blocking a molecule called asparagine. But what does this mean for patients?